ArticleScientific reports2026

In silico evaluation of (benzo)chromeno[3,4-c]pyridine derivative as dual EGFR/HER2 inhibitors for non-small cell lung cancer.

Uduak Luke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.